National University Corporation Tottori University;KanonCure, Inc.
发明人:
申请号：
EP15769676.6
公开号：
EP3150207B1
申请日:
2015.03.25
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
A novel therapeutic drug for malignant tumors, cancer stem cells, or fibrosis is obtained. A therapeutic drug for malignant tumors or cancer stem cells is used that includes at least one compound selected from the group consisting of compounds represented by formulas (1), (2), and (5), a salt thereof, or a solvate thereof. Alternatively, a therapeutic drug for fibrosis can be used that includes at least one compound selected from the group consisting of compounds represented by formulas (1), (2), and (5), a salt thereof, or a solvate thereof.
